G. Schellong
- Hematology top 1%
- Acute Myeloid Leukemia Research 28
- Blood groups and transfusion 9
-
- Lymphoma Diagnosis and Treatment 30
-
- Acute Lymphoblastic Leukemia research 41
- Neurology top 2%
-
- Childhood Cancer Survivors' Quality of Life 13
-
- Blood disorders and treatments 12
-
- Neutropenia and Cancer Infections 10
-
- Lung Cancer Treatments and Mutations 9
G. Schellong
99 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 94
- Hematology 825
- Pathology and Forensic Medicine 1.2k
- Public Health, Environmental and Occupational Health 1.2k
- Neurology 557
- Pediatrics, Perinatology and Child Health 617
Countries citing papers authored by G. Schellong
This map shows the geographic impact of G. Schellong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Schellong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Schellong more than expected).
Fields of papers citing papers by G. Schellong
This network shows the impact of papers produced by G. Schellong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Schellong. The network helps show where G. Schellong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G. Schellong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 29 | |
| 2 | 2014 | 35 | |
| 3 | 2005 | 153 | |
| 4 | 2003 | 13 | |
| 5 | 2003 | 22 | |
| 6 | 2002 | 22 | |
| 7 | 1998 | 20 | |
| 8 | 1998 | 3 | |
| 9 | 1996 | 37 | |
| 10 | 1994 | 20 | |
| 11 | 1993 | 75 | |
| 12 | 1992 | 10 | |
| 13 | 1992 | 22 | |
| 14 | 1991 | 41 | |
| 15 | 1990 | 17 | |
| 16 | 1990 | 1 | |
| 17 | 1989 | 12 | |
| 18 | 1987 | 84 | |
| 19 | 1984 | 1 | |
| 20 | [The prognostic value of measuring cell size in acute childhood leukemia (author's transl)]. | 1979 | 1 |
About G. Schellong
G. Schellong is a scholar working on Hematology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health, having authored 106 papers that have together received 2.6k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (41 papers), Lymphoma Diagnosis and Treatment (30 papers), Acute Myeloid Leukemia Research (28 papers), Childhood Cancer Survivors' Quality of Life (13 papers), Blood disorders and treatments (12 papers), Neutropenia and Cancer Infections (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Blood groups and transfusion (9 papers). The work is most often cited by research in Hematology (825 citations), Pathology and Forensic Medicine (1.2k citations) and Public Health, Environmental and Occupational Health (1.2k citations). G. Schellong has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include J. Ritter, Jürgen Brämswig, Ursula Creutzig, W Dörffel, Marianne Riepenhausen, Richard Pötter, Alfred Reiter, Hansjörg Riehm, M Zimmermann and G. Henze. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Annals of Oncology and Recent results in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.